Felis consequat magnis est fames sagittis ultrices placerat sodales porttitor quisque.
In barely a decade, China has transformed from a maker of cheap generic copies of Western medicines into a global powerhouse of pharmaceutical innovation.
The country now only trails the United States in novel drugs under development, with a 29 per cent share, according to McKinsey. International pharmaceutical companies are beating a path to China’s shores to license next-generation treatments for cancer, autoimmune diseases and other disorders.
Government support, including regulatory and…
Media365India’s wholesale inflation rose to 9.68 per cent in May from 8.30 per cent in April, driven by higher fuel, food and manufacturing costs, marking the first reading under the…
Media365Indonesia’s increasingly assertive control over its vast nickel resources has triggered an unusually public backlash from China, with Beijing warning that regulatory changes in the world’s largest nickel-producing nation could…
